Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
In this cohort study, midlife hearing loss was linked with smaller brain volumes, faster decline in executive function, and a ...
Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of lifeTHE WOODLANDS, Texas, Nov. 08, 2025 ...
News-Medical.Net on MSN
Single daily polypill improves heart function and quality of life in heart failure patients
Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...
A joint study by the University Medical Center Göttingen (UMG) and the University Hospital Würzburg provides new insights ...
Discover the incredible health benefits of bamboo shoots, a nutrient-dense food packed with fibre, vitamins, and antioxidants ...
Explore the alarming rise of early cardiac disease among corporate professionals in India, driven by long hours, stress, and ...
Enamel does not regenerate; once you lose it it's gone forever. There is currently no solution available that can effectively ...
18d
zSpace Expands Health Science Portfolio with New Immersive Applications for Anatomy and ECG Training
(GLOBE NEWSWIRE) -- (NASDAQ: ZSPC), a global leader in immersive augmented (AR) solutions for education, today announced two ...
Julius Ryan D. Pronto, et al. Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial Fibrillation. Circulation Research (2025). DOI: https://doi.org/10.1161/CIRCRESAHA.124.325658 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback